Sun Pharma

Sun down on latest Indian US FDA import alert

Sun down on latest Indian US FDA import alert

By Dan Stanton

Sun Pharma’s antibiotic facility import alert is the latest blow to the Indian drug industry but is unlikely to impact revenues or cause US shortages, the firm says.